{
  "abstract": {
    "textEnglish": "A Gamma Variant RBD-based aluminum hydroxide adjuvanted vaccine called ARVAC CG was selected for a first in human clinical trial. Healthy male and female participants (18-55 years old) with a complete COVID-19-primary vaccine scheme were assigned to receive two intramuscular doses of either a low-dose or a high-dose of ARVAC CG. The primary endpoint was safety. The secondary objective was humoral immunogenicity. Cellular immune responses were studied as an exploratory objective. The trial was prospectively registered in PRIISA.BA (Registration Code 6564) and ANMAT and retrospectively registered in ClinicalTrials.gov (NCT05656508). Samples from participants of a surveillance strategy implemented by the Ministry of Health of the Province of Buenos Aires that were boosted with BNT162b2 were also analyzed to compare with the booster effect of ARVAC CG. ARVAC CG exhibits a satisfactory safety profile, a robust and broad booster response of neutralizing antibodies against the Ancestral strain of SARS-CoV-2 and the Gamma, Delta, Omicron BA.1 and Omicron BA.5 variants of concern and a booster effect on T cell immunity in individuals previously immunized with different COVID-19 vaccine platforms."
  },
  "authors": [
    {
      "affiliation": [
        {
          "affPubID": "Aff1",
          "affPubRaw": "Instituto de Investigaciones Biotecnol\u00f3gicas Universidad Nacional de San Mart\u00edn (UNSAM) \u2013 Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) San Mart\u00edn (1650) Buenos Aires Argentina"
        },
        {
          "affPubID": "Aff2",
          "affPubRaw": "Escuela de Bio y Nanotecnolog\u00edas (EByN) Universidad Nacional de San Mart\u00edn San Mart\u00edn (1650) Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "email": "kpasquevich@iib.unsam.edu.ar",
        "orcid": "0000-0003-4448-0977"
      },
      "name": {
        "given_name": "Karina A.",
        "surname": "Pasquevich"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff1",
          "affPubRaw": "Instituto de Investigaciones Biotecnol\u00f3gicas Universidad Nacional de San Mart\u00edn (UNSAM) \u2013 Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) San Mart\u00edn (1650) Buenos Aires Argentina"
        },
        {
          "affPubID": "Aff2",
          "affPubRaw": "Escuela de Bio y Nanotecnolog\u00edas (EByN) Universidad Nacional de San Mart\u00edn San Mart\u00edn (1650) Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "orcid": "0000-0001-5359-8382"
      },
      "name": {
        "given_name": "Lorena M.",
        "surname": "Coria"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff3",
          "affPubRaw": "Instituto de Investigaciones Biom\u00e9dicas en Retrovirus y SIDA, INBIRS-CONICET Facultad de Medicina UBA Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Ana",
        "surname": "Ceballos"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff3",
          "affPubRaw": "Instituto de Investigaciones Biom\u00e9dicas en Retrovirus y SIDA, INBIRS-CONICET Facultad de Medicina UBA Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Bianca",
        "surname": "Mazzitelli"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff4",
          "affPubRaw": "Fundaci\u00f3n Pablo Cassar\u00e1 - Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Juan Manuel",
        "surname": "Rodriguez"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff1",
          "affPubRaw": "Instituto de Investigaciones Biotecnol\u00f3gicas Universidad Nacional de San Mart\u00edn (UNSAM) \u2013 Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) San Mart\u00edn (1650) Buenos Aires Argentina"
        },
        {
          "affPubID": "Aff2",
          "affPubRaw": "Escuela de Bio y Nanotecnolog\u00edas (EByN) Universidad Nacional de San Mart\u00edn San Mart\u00edn (1650) Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Agostina",
        "surname": "Demar\u00eda"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff1",
          "affPubRaw": "Instituto de Investigaciones Biotecnol\u00f3gicas Universidad Nacional de San Mart\u00edn (UNSAM) \u2013 Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) San Mart\u00edn (1650) Buenos Aires Argentina"
        },
        {
          "affPubID": "Aff2",
          "affPubRaw": "Escuela de Bio y Nanotecnolog\u00edas (EByN) Universidad Nacional de San Mart\u00edn San Mart\u00edn (1650) Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Celeste",
        "surname": "Pueblas Castro"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff1",
          "affPubRaw": "Instituto de Investigaciones Biotecnol\u00f3gicas Universidad Nacional de San Mart\u00edn (UNSAM) \u2013 Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) San Mart\u00edn (1650) Buenos Aires Argentina"
        },
        {
          "affPubID": "Aff2",
          "affPubRaw": "Escuela de Bio y Nanotecnolog\u00edas (EByN) Universidad Nacional de San Mart\u00edn San Mart\u00edn (1650) Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Laura",
        "surname": "Bruno"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff1",
          "affPubRaw": "Instituto de Investigaciones Biotecnol\u00f3gicas Universidad Nacional de San Mart\u00edn (UNSAM) \u2013 Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) San Mart\u00edn (1650) Buenos Aires Argentina"
        },
        {
          "affPubID": "Aff2",
          "affPubRaw": "Escuela de Bio y Nanotecnolog\u00edas (EByN) Universidad Nacional de San Mart\u00edn San Mart\u00edn (1650) Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Lucas",
        "surname": "Saposnik"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff3",
          "affPubRaw": "Instituto de Investigaciones Biom\u00e9dicas en Retrovirus y SIDA, INBIRS-CONICET Facultad de Medicina UBA Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Melina",
        "surname": "Salvatori"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff3",
          "affPubRaw": "Instituto de Investigaciones Biom\u00e9dicas en Retrovirus y SIDA, INBIRS-CONICET Facultad de Medicina UBA Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Augusto",
        "surname": "Varese"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff5",
          "affPubRaw": "Ministerio de Salud de la Provincia de Buenos Aires Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Soledad",
        "surname": "Gonz\u00e1lez"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff5",
          "affPubRaw": "Ministerio de Salud de la Provincia de Buenos Aires Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "orcid": "0000-0001-5231-1773"
      },
      "name": {
        "given_name": "Veronica V.",
        "surname": "Gonz\u00e1lez Mart\u00ednez"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff3",
          "affPubRaw": "Instituto de Investigaciones Biom\u00e9dicas en Retrovirus y SIDA, INBIRS-CONICET Facultad de Medicina UBA Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Jorge",
        "surname": "Geffner"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff1",
          "affPubRaw": "Instituto de Investigaciones Biotecnol\u00f3gicas Universidad Nacional de San Mart\u00edn (UNSAM) \u2013 Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) San Mart\u00edn (1650) Buenos Aires Argentina"
        },
        {
          "affPubID": "Aff2",
          "affPubRaw": "Escuela de Bio y Nanotecnolog\u00edas (EByN) Universidad Nacional de San Mart\u00edn San Mart\u00edn (1650) Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Diego",
        "surname": "\u00c1lvarez"
      }
    },
    {
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Sabrina A.",
        "surname": "del Priore"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff1",
          "affPubRaw": "Instituto de Investigaciones Biotecnol\u00f3gicas Universidad Nacional de San Mart\u00edn (UNSAM) \u2013 Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) San Mart\u00edn (1650) Buenos Aires Argentina"
        },
        {
          "affPubID": "Aff4",
          "affPubRaw": "Fundaci\u00f3n Pablo Cassar\u00e1 - Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Andr\u00e9s C.",
        "surname": "Hernando Insua"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Ingrid G.",
        "surname": "Kaufmann"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff1",
          "affPubRaw": "Instituto de Investigaciones Biotecnol\u00f3gicas Universidad Nacional de San Mart\u00edn (UNSAM) \u2013 Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) San Mart\u00edn (1650) Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Adri\u00e1n",
        "surname": "Di Mar\u00eda"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Adri\u00e1n",
        "surname": "G\u00f3ngora"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Agust\u00edn",
        "surname": "Moreno"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Susana",
        "surname": "Cervellini"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Blasco",
        "surname": "Martin"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Esteban",
        "surname": "Ali"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Romina",
        "surname": "Albarrac\u00edn"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Barsanti",
        "surname": "Bruno"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Fernando",
        "surname": "Toneguzzo"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Guillermina",
        "surname": "Sasso"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Sebastian",
        "surname": "Stamer"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Regina",
        "surname": "Cardoso"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "collab": true
      },
      "name": {
        "collab": "Laboratorio Pablo Cassar\u00e1 R&D and CMC for ARVAC CG consortium",
        "given_name": "Alejandro",
        "surname": "Chajet"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff6",
          "affPubRaw": "FP CLINICAL PHARMA Ciudad Aut\u00f3noma de Buenos Aires Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Ethel",
        "surname": "Feleder"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff6",
          "affPubRaw": "FP CLINICAL PHARMA Ciudad Aut\u00f3noma de Buenos Aires Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Karina",
        "surname": "Halabe"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff6",
          "affPubRaw": "FP CLINICAL PHARMA Ciudad Aut\u00f3noma de Buenos Aires Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Pablo E.",
        "surname": "Perez Lera"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Federico Montes",
        "surname": "de Oca"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Julio C.",
        "surname": "Vega"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff8",
          "affPubRaw": "Nobeltri Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "M\u00f3nica",
        "surname": "Lombardo"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff6",
          "affPubRaw": "FP CLINICAL PHARMA Ciudad Aut\u00f3noma de Buenos Aires Buenos Aires Argentina"
        }
      ],
      "name": {
        "given_name": "Gustavo A.",
        "surname": "Yerino"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff7",
          "affPubRaw": "Laboratorio Pablo Cassar\u00e1 \u2013 Unidad de I + D de Biof\u00e1rmacos Saladillo 2452 C1440FFX Ciudad Aut\u00f3noma de Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "orcid": "0000-0002-0051-7435"
      },
      "name": {
        "given_name": "Juan",
        "surname": "Fl\u00f3"
      }
    },
    {
      "affiliation": [
        {
          "affPubID": "Aff1",
          "affPubRaw": "Instituto de Investigaciones Biotecnol\u00f3gicas Universidad Nacional de San Mart\u00edn (UNSAM) \u2013 Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET) San Mart\u00edn (1650) Buenos Aires Argentina"
        },
        {
          "affPubID": "Aff2",
          "affPubRaw": "Escuela de Bio y Nanotecnolog\u00edas (EByN) Universidad Nacional de San Mart\u00edn San Mart\u00edn (1650) Buenos Aires Argentina"
        }
      ],
      "attrib": {
        "email": "jucassataro@iib.unsam.edu.ar",
        "orcid": "0000-0002-7122-869X"
      },
      "name": {
        "given_name": "Juliana",
        "surname": "Cassataro"
      }
    }
  ],
  "copyright": {
    "statement": "\u00a9 The Author(s) 2023",
    "status": true
  },
  "editorialHistory": {
    "acceptedDate": "2023-07-20",
    "receivedDates": [
      "2023-02-17"
    ]
  },
  "pagination": {
    "electronicID": "4551"
  },
  "persistentIDs": [
    {
      "DOI": "10.1038/s41467-023-40272-3"
    }
  ],
  "pubDate": {
    "electrDate": "2023-12-00"
  },
  "publication": {
    "ISSN": [
      {
        "issnString": "2041-1723",
        "pubtype": "epub"
      }
    ],
    "issueNum": "1",
    "pubName": "Nature Communications",
    "pubYear": "2023",
    "publisher": "Nature Publishing Group UK",
    "volumeNum": "14"
  },
  "publisherIDs": [
    {
      "Identifier": "s41467-023-40272-3",
      "attribute": "publisher-id"
    },
    {
      "Identifier": "40272",
      "attribute": "manuscript"
    }
  ],
  "recordData": {
    "createdTime": "",
    "loadFormat": "JATS",
    "loadLocation": "",
    "loadType": "fromFile",
    "parsedTime": "",
    "recordOrigin": ""
  },
  "references": [
    "<ref id=\"CR1\"> <label>1.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Chi</surname> <given-names>W-Y</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection</article-title> <source>J. Biomed. Sci.</source> <year>2022</year> <volume>29</volume> <pub-id pub-id-type=\"doi\">10.1186/s12929-022-00853-8</pub-id> <pub-id pub-id-type=\"pmid\">36243868</pub-id> <pub-id pub-id-type=\"pmcid\">9569411</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR2\"> <label>2.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Shrestha</surname> <given-names>LB</given-names> </name> <name> <surname>Foster</surname> <given-names>C</given-names> </name> <name> <surname>Rawlinson</surname> <given-names>W</given-names> </name> <name> <surname>Tedla</surname> <given-names>N</given-names> </name> <name> <surname>Bull</surname> <given-names>RA</given-names> </name> </person-group> <article-title xml:lang=\"en\">Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission</article-title> <source>Rev. Med Virol.</source> <year>2022</year> <volume>32</volume> <fpage>e2381</fpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38XitVWksr%2FO</pub-id> <pub-id pub-id-type=\"doi\">10.1002/rmv.2381</pub-id> <pub-id pub-id-type=\"pmid\">35856385</pub-id> <pub-id pub-id-type=\"pmcid\">9349777</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR3\"> <label>3.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Martinez-Flores</surname> <given-names>D</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants</article-title> <source>Front Immunol.</source> <year>2021</year> <volume>12</volume> <fpage>701501</fpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB3MXitFKgt7vO</pub-id> <pub-id pub-id-type=\"doi\">10.3389/fimmu.2021.701501</pub-id> <pub-id pub-id-type=\"pmid\">34322129</pub-id> <pub-id pub-id-type=\"pmcid\">8311925</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR4\"> <label>4.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pollet</surname> <given-names>J</given-names> </name> <name> <surname>Chen</surname> <given-names>WH</given-names> </name> <name> <surname>Strych</surname> <given-names>U</given-names> </name> </person-group> <article-title xml:lang=\"en\">Recombinant protein vaccines, a proven approach against coronavirus pandemics</article-title> <source>Adv. Drug Deliv. Rev.</source> <year>2021</year> <volume>170</volume> <fpage>71</fpage> <lpage>82</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB3MXhsVeqsrw%3D</pub-id> <pub-id pub-id-type=\"doi\">10.1016/j.addr.2021.01.001</pub-id> <pub-id pub-id-type=\"pmid\">33421475</pub-id> <pub-id pub-id-type=\"pmcid\">7788321</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR5\"> <label>5.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Heidary</surname> <given-names>M</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19</article-title> <source>Front Microbiol</source> <year>2022</year> <volume>13</volume> <fpage>927306</fpage> <pub-id pub-id-type=\"doi\">10.3389/fmicb.2022.927306</pub-id> <pub-id pub-id-type=\"pmid\">35910658</pub-id> <pub-id pub-id-type=\"pmcid\">9329957</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR6\"> <label>6.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pascuale</surname> <given-names>CA</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273</article-title> <source>Cell Rep. Med.</source> <year>2022</year> <volume>3</volume> <fpage>100706</fpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38XitVGgtLjP</pub-id> <pub-id pub-id-type=\"doi\">10.1016/j.xcrm.2022.100706</pub-id> <pub-id pub-id-type=\"pmid\">35926505</pub-id> <pub-id pub-id-type=\"pmcid\">9346506</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR7\"> <label>7.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Rearte</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study</article-title> <source>Lancet</source> <year>2022</year> <volume>399</volume> <fpage>1254</fpage> <lpage>1264</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38XnsFClt7c%3D</pub-id> <pub-id pub-id-type=\"doi\">10.1016/S0140-6736(22)00011-3</pub-id> <pub-id pub-id-type=\"pmid\">35303473</pub-id> <pub-id pub-id-type=\"pmcid\">8923678</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR8\"> <label>8.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Cele</surname> <given-names>S</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization</article-title> <source>Nature</source> <year>2022</year> <volume>602</volume> <fpage>654</fpage> <lpage>656</lpage> <pub-id pub-id-type=\"bibcode\">2022Natur.602..654C</pub-id> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38XjvFOktLw%3D</pub-id> <pub-id pub-id-type=\"doi\">10.1038/s41586-021-04387-1</pub-id> <pub-id pub-id-type=\"pmid\">35016196</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR9\"> <label>9.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kuhlmann</surname> <given-names>C</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose</article-title> <source>Lancet</source> <year>2022</year> <volume>399</volume> <fpage>625</fpage> <lpage>626</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38Xhs1amtbc%3D</pub-id> <pub-id pub-id-type=\"doi\">10.1016/S0140-6736(22)00090-3</pub-id> <pub-id pub-id-type=\"pmid\">35063123</pub-id> <pub-id pub-id-type=\"pmcid\">8765759</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR10\"> <label>10.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Launay</surname> <given-names>O</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine</article-title> <source>N. Engl. J. Med.</source> <year>2022</year> <volume>387</volume> <fpage>374</fpage> <lpage>376</lpage> <pub-id pub-id-type=\"doi\">10.1056/NEJMc2206711</pub-id> <pub-id pub-id-type=\"pmid\">35767474</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR11\"> <label>11.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Choi</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis</article-title> <source>Nat. Med.</source> <year>2021</year> <volume>27</volume> <fpage>2025</fpage> <lpage>2031</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB3MXitVequ7bM</pub-id> <pub-id pub-id-type=\"doi\">10.1038/s41591-021-01527-y</pub-id> <pub-id pub-id-type=\"pmid\">34526698</pub-id> <pub-id pub-id-type=\"pmcid\">8604720</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR12\"> <label>12.</label> <mixed-citation publication-type=\"other\">Branche, A. R. et al. SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses. \t\t\t\t\t\t<italic>medRxiv</italic>, \t\t\t\t\t\t<ext-link ext-link-type=\"doi\" xlink:href=\"https://doi.org/10.1101/2022.07.12.22277336\">https://doi.org/10.1101/2022.07.12.22277336</ext-link> (2022). \t\t\t\t\t</mixed-citation> </ref>",
    "<ref id=\"CR13\"> <label>13.</label> <mixed-citation publication-type=\"other\">Coria, L. M. et al. A Gamma-adapted recombinant subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from SARS-CoV-2 infection. \t\t\t\t\t\t<italic>bioRxiv</italic>, 2023.2001.2003.522213, \t\t\t\t\t\t<ext-link ext-link-type=\"doi\" xlink:href=\"https://doi.org/10.1101/2023.01.03.522213\">https://doi.org/10.1101/2023.01.03.522213</ext-link> (2023). \t\t\t\t\t</mixed-citation> </ref>",
    "<ref id=\"CR14\"> <label>14.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Carazo</surname> <given-names>S</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study</article-title> <source>Lancet Infect. Dis.</source> <year>2022</year> <volume>23</volume> <fpage>45</fpage> <lpage>55</lpage> <pub-id pub-id-type=\"doi\">10.1016/S1473-3099(22)00578-3</pub-id> <pub-id pub-id-type=\"pmid\">36152671</pub-id> <pub-id pub-id-type=\"pmcid\">9491856</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR15\"> <label>15.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Khoury</surname> <given-names>DS</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection</article-title> <source>Nat. Med</source> <year>2021</year> <volume>27</volume> <fpage>1205</fpage> <lpage>1211</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB3MXhtFSktLrP</pub-id> <pub-id pub-id-type=\"doi\">10.1038/s41591-021-01377-8</pub-id> <pub-id pub-id-type=\"pmid\">34002089</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR16\"> <label>16.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gilbert</surname> <given-names>PB</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial</article-title> <source>Science</source> <year>2022</year> <volume>375</volume> <fpage>43</fpage> <lpage>50</lpage> <pub-id pub-id-type=\"bibcode\">2022Sci...375...43G</pub-id> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38Xhtlamu70%3D</pub-id> <pub-id pub-id-type=\"doi\">10.1126/science.abm3425</pub-id> <pub-id pub-id-type=\"pmid\">34812653</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR17\"> <label>17.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Chalkias</surname> <given-names>S</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial</article-title> <source>Nat. Med</source> <year>2022</year> <volume>28</volume> <fpage>2388</fpage> <lpage>2397</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38XisFygu7bL</pub-id> <pub-id pub-id-type=\"doi\">10.1038/s41591-022-02031-7</pub-id> <pub-id pub-id-type=\"pmid\">36202997</pub-id> <pub-id pub-id-type=\"pmcid\">9671805</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR18\"> <label>18.</label> <mixed-citation publication-type=\"other\">Lien, C. E. et al. \t\t\t\t\t\t<italic>A Phase I, Prospective, Randomized, Open-labeled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901(Beta) SARS-CoV-2 Vaccine in Adults</italic> (Cold Spring Harbor Laboratory, 2022). \t\t\t\t\t</mixed-citation> </ref>",
    "<ref id=\"CR19\"> <label>19.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Feng</surname> <given-names>S</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection</article-title> <source>Nat. Med.</source> <year>2021</year> <volume>27</volume> <fpage>2032</fpage> <lpage>2040</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB3MXitFCit7%2FL</pub-id> <pub-id pub-id-type=\"doi\">10.1038/s41591-021-01540-1</pub-id> <pub-id pub-id-type=\"pmid\">34588689</pub-id> <pub-id pub-id-type=\"pmcid\">8604724</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR20\"> <label>20.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Goldblatt</surname> <given-names>D</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Towards a population-based threshold of protection for COVID-19 vaccines</article-title> <source>Vaccine</source> <year>2022</year> <volume>40</volume> <fpage>306</fpage> <lpage>315</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38XntFyhtw%3D%3D</pub-id> <pub-id pub-id-type=\"doi\">10.1016/j.vaccine.2021.12.006</pub-id> <pub-id pub-id-type=\"pmid\">34933765</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR21\"> <label>21.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Fong</surname> <given-names>Y</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial</article-title> <source>Nat. Microbiol.</source> <year>2022</year> <volume>7</volume> <fpage>1996</fpage> <lpage>2010</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38XivVGltbbM</pub-id> <pub-id pub-id-type=\"doi\">10.1038/s41564-022-01262-1</pub-id> <pub-id pub-id-type=\"pmid\">36357712</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR22\"> <label>22.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wherry</surname> <given-names>EJ</given-names> </name> <name> <surname>Barouch</surname> <given-names>DH</given-names> </name> </person-group> <article-title xml:lang=\"en\">T cell immunity to COVID-19 vaccines</article-title> <source>Science</source> <year>2022</year> <volume>377</volume> <fpage>821</fpage> <lpage>822</lpage> <pub-id pub-id-type=\"bibcode\">2022Sci...377..821W</pub-id> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38Xit1yrtL7O</pub-id> <pub-id pub-id-type=\"doi\">10.1126/science.add2897</pub-id> <pub-id pub-id-type=\"pmid\">35981045</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR23\"> <label>23.</label> <mixed-citation publication-type=\"other\">Maringer, Y. et al. Durable spike-specific T-cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination. \t\t\t\t\t\t<italic>Sci Immunol.</italic> <bold>7</bold>. eadd3899, (2022). \t\t\t\t\t</mixed-citation> </ref>",
    "<ref id=\"CR24\"> <label>24.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Payne</surname> <given-names>RP</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine</article-title> <source>Cell</source> <year>2021</year> <volume>184</volume> <fpage>5699</fpage> <lpage>5714.e5611</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB3MXisVantbnM</pub-id> <pub-id pub-id-type=\"doi\">10.1016/j.cell.2021.10.011</pub-id> <pub-id pub-id-type=\"pmid\">34735795</pub-id> <pub-id pub-id-type=\"pmcid\">8519781</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR25\"> <label>25.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhao</surname> <given-names>X</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants</article-title> <source>Lancet Microbe</source> <year>2021</year> <volume>2</volume> <fpage>e494</fpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB3MXisVers7fP</pub-id> <pub-id pub-id-type=\"doi\">10.1016/S2666-5247(21)00217-2</pub-id> <pub-id pub-id-type=\"pmid\">34458880</pub-id> <pub-id pub-id-type=\"pmcid\">8378832</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR26\"> <label>26.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhao</surname> <given-names>X</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant</article-title> <source>N. Engl. J. Med.</source> <year>2022</year> <volume>386</volume> <fpage>894</fpage> <lpage>896</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB38Xmslamu7c%3D</pub-id> <pub-id pub-id-type=\"doi\">10.1056/NEJMc2119426</pub-id> <pub-id pub-id-type=\"pmid\">35081296</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR27\"> <label>27.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Rosenblum</surname> <given-names>HG</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022</article-title> <source>MMWR Morb. Mortal. Wkly Rep.</source> <year>2022</year> <volume>71</volume> <fpage>1436</fpage> <lpage>1441</lpage> <pub-id pub-id-type=\"doi\">10.15585/mmwr.mm7145a2</pub-id> <pub-id pub-id-type=\"pmid\">36355612</pub-id> <pub-id pub-id-type=\"pmcid\">9707353</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR28\"> <label>28.</label> <mixed-citation publication-type=\"other\">FDA. in \t\t\t\t\t\t<italic>Guidance for Industry</italic> (ed U.S._Department_of_Health_and_Human_Services) (2007). \t\t\t\t\t</mixed-citation> </ref>",
    "<ref id=\"CR29\"> <label>29.</label> <mixed-citation publication-type=\"other\">CIOMS/WHO. Definition and Application of Terms for Vaccine Pharmacovigilance. (Working Group on Vaccine Pharmacovigilance. Council for International Organizations of Medical Sciences (CIOMS), World health organization (WHO), Geneva, 2012).</mixed-citation> </ref>",
    "<ref id=\"CR30\"> <label>30.</label> <mixed-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Varese</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title xml:lang=\"en\">Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response</article-title> <source>J. Infect. Dis.</source> <year>2022</year> <volume>226</volume> <fpage>1717</fpage> <lpage>1720</lpage> <pub-id pub-id-type=\"coi\">1:CAS:528:DC%2BB3sXptFart7w%3D</pub-id> <pub-id pub-id-type=\"doi\">10.1093/infdis/jiac250</pub-id> <pub-id pub-id-type=\"pmid\">35723970</pub-id> </mixed-citation> </ref>",
    "<ref id=\"CR31\"> <label>31.</label> <mixed-citation publication-type=\"other\">World_Health_Organization. WHO manual for the establishment of national and other secondary standards for antibodies against infectious agents focusing on SARSCoV2. (World Health Organization, 2022).</mixed-citation> </ref>"
  ],
  "title": {
    "textEnglish": "Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults"
  }
}
